Used in pharmaceutical research as a key intermediate in the synthesis of protease inhibitors, particularly in the development of drugs targeting viral enzymes such as those in hepatitis C and HIV. Its structure supports high binding affinity to enzyme active sites, making it valuable in designing potent and selective inhibitors. Also investigated for use in treatments requiring improved metabolic stability and bioavailability due to its modified peptide backbone.